Skip to content
Search

Latest Stories

Superdrug reports strong sales and profit growth amid high street expansion

Superdrug reports strong sales and profit growth amid high street expansion

Superdrug added 14 outlets last year and plans to open an additional 25 new high street stores this year

The renowned health and beauty chain has announced impressive annual sales and profit figures, following the expansion of its British high street estate.


According to a report by The Times, Superdrug’s pre-tax profits jumped by 43.6 per cent to £111.6 million in the year ending December 2023 compared to the previous year.

The company’s revenue also experienced significant growth, rising by 11.8 per cent to reach £1.52 billion, marking its third consecutive year of market share growth.

Key factors driving this growth include the opening of 14 new stores across strategic locations such as The Trafford Centre in Manchester and Brent Cross shopping centre in north London, and the refitting of 45 stores last year.

Additionally, the continued expansion of its cheaper, own-label products, along with exclusive launches from brands like Bioré SPF, Nyx X Barbie, and Billie Eilish fragrances, significantly contributed to a 4.2 per cent year-on-year increase in Superdrug's sales volume.

Founded in 1964, Superdrug is owned by AS Watson Holdings, headquartered in Hong Kong. With 784 stores in the UK and Republic of Ireland, it remains the second largest beauty retailer on the high street, trailing behind Boots.

Peter Macnab, chief executive of Superdrug, told The Times that the company has made significant investments to keep their prices competitive as inflation continues to put pressure on households.

However, the group expects that the UK retail environment will remain “challenging and strongly competitive” in 2024, with a heavy focus on price.

Nevertheless, the company remains optimistic about its growth prospects, believing that the right retail proposition and customer service will drive success.

Superdrug has already announced its plan to launch 25 new stores this year as it celebrates its 60th year on the British high street. The opening of these new stores is anticipated to generate over 500 jobs nationwide.

In May, the retailer confirmed the locations for four upcoming stores – Wheatley Centre Shopping Parkin Doncaster, St David’s Centre in Cardiff, Bluewater Shopping Centre and Westfield Stratford City.

Additionally, there are plans to expand seven existing branches and refit another 60 throughout 2024.

Currently, Superdrug operates over 830 stores across the UK and the Republic of Ireland, including 200 in-store pharmacies. With these new openings, the total number of brick-and-mortar stores will exceed 850.

Rival Boots also reported robust a surge in pre-tax profits for its latest financial year.

It reported a 5.9 per cent increase in retail sales for the three months ending on February 29, 2024, marking its twelfth consecutive quarter of growth in retail market share.

Significant growth was seen across digital platforms, including Boots.com and the Boots app, with digital sales surging by 16.8 per cent, largely due to "strong sales of beauty and personal care products."

In-store sales also showed steady growth, rising by 4.5 per cent, with flagship, shopping center, and travel stores performing particularly well.

Boots, part of Walgreens Boots Alliance, operates a network of more than 2,100 stores across the UK, ranging from local community pharmacies to large destination health and beauty stores, and employs over 52,000 team members nationwide.

Read more news related to Superdrug

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less